Search Results - Aaron Boster

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

    Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis by Aaron Boster, Mary Pat Bartoszek, Colleen O’Connell, David Pitt, Michael Racke

    Published 2011-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

    Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. by Veela Mehta, Wei Pei, Grant Yang, Suyang Li, Eashwar Swamy, Aaron Boster, Petra Schmalbrock, David Pitt

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings

    Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings by Krista Barclay, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher LaGanke, Antonio Bertolotto, Aaron Boster, Elisabeth G. Celius, Jérôme de Seze, Dionisio Dela Cruz, Mario Habek, Jong-Mi Lee, Volker Limmroth, Sven G. Meuth, Celia Oreja-Guevara, Patricia Pagnotta, Cindy Vos, Tjalf Ziemssen, Darren P. Baker, Bart Van Wijmeersch

    Published 2019-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: